5 CSF 6 CSF 7 CSF CSF CDV CDV GFAP CSF Pandy test NSE MBP LDH mu/ml 0-5 /µl AST mu/ml CK mu/ml <25 mg/dl<45 mg/dl GLU

Similar documents
日本呼吸器学会雑誌第44巻第10号

日本呼吸器学会雑誌第47巻第6号

_02三浦.indd

Atlas_j060419

慈大呼吸器_25-1_02T_CS5.indd

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742

ベーリンガー共立A4.CS

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

Sample2 g/dl Target1 : 6.01 g/dl TP Target2 : 8.39 g/dl

(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..

日本呼吸器学会雑誌第44巻第1号

125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10

sick contact1l

BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI

九州支部卒後研修会症例

/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 3 2 5/ :90 / :114/64 mmhg


untitled

デスフルラン

/ B B ( ) ( -298) VL VH( ) Very Low( ) Very High( ) ( 10 2 %) (g/l) ( 10 2 %) 0.75 ( 10 2 %) 0.15 ( 10 2 %)

051

,

GJG160842_O.QXD

血糖高いのは朝食後のため検査項目 下限値上限値 単位名称 9 月 3 日 9 月 6 日 9 月 15 日 9 月 18 日 9 月 21 日 9 月 24 日 9 月 28 日 10 月 1 日 10 月 3 日 10 月 5 日 10 月 9 日 10 月 12 日 10 月 15 日 10 月

Valganciclovir 1 CMV valganciclovir VGCV CMV IgM CMV-DNA CMV 34 VGCV 2 1 CMV CMV ganciclovir valganciclovir MRI cytomegaloviru

untitled

1 Q A 82% 89% 88% 82% 88% 82%

1) Urlne analysls 7)Serologlcal exam. 1 1)ECG W.N.L. sugar 0% CRP (-) urobillnogen N(+) RA (+) 12)Renal function albumin 3(+) ASLO (-) PSP test 15' 40

高脂血症の検査

45 40 : Blood transfusion(100ml) PCV(%) Days Prednisolone Mesalazine Chlorambucil Cyclospo

2 129-B*-006P 129-B*-007P C*-004P 129-D*-001P ADH B*-006P B*-007P C*-004P D*-001P Na

indd

untitled

72 20 Ope / class Alb g/ cm 47.9kg : /min 112/60m

m 3 /s

untitled

日本呼吸器学会雑誌第48巻第6号

1 2 2 ANCA pouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - ' UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, cm 61

387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )

日本医師会雑誌第131巻第10号

ml ml ~ml : ml

1) a) b) CRP c) d) e) a,b b,c c,d d,e a,e b,d 2) CKD a) ACE ARB b) 2mg/dL ACE ARB c) 2mg/dL d) e) ACE ARB a,b b,c c,d d,e a,e b,d 3) a) 130/85mmHg b)


0.45m1.00m 1.00m 1.00m 0.33m 0.33m 0.33m 0.45m 1.00m 2

津村漢方雑誌表紙_ol.ai

空き容量一覧表(154kV以上)

2/8 一次二次当該 42 AX 変圧器 なし 43 AY 変圧器 なし 44 BA 変圧器 なし 45 BB 変圧器 なし 46 BC 変圧器 なし

_06.indd

Microsoft Word - 平成24年度医学部卒業試験問題-2.docx

SARS HIV/AIDS n = 672; % 5% 2% 8% 16% 43% 20%

VOL.39 S-3

1996 papilloma virus 2001 Bowen AIHA PSL1mg/kg BMA PRCA parvovirus B19 PVB19 DNA PCR PV IgM 4 PVB19 PRCA MAP PVB19 DNA DNA PR

2010 年 6 月 25 表 身体所見 134 cm 31 kg /60 mmhg 83/ ,


/ / A/ B 16/17 COPD 18mcg COPD COPD COPD 1

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml

untitled

05 agon Inaba 149

当院の血液検査室の概要 血液検査 system 自動血球分析装置塗抹標本作製装置 La-vietal LS (Sysmex 社 ) XN-3000 (Sysmex 社 ) XN 台 ( RET WPC PLT-F の各チャンネル ) XN 台 SP-10 (Sysmex

表 1 入院時検査所見 11,500L 471 L 17.0 gdl.3 L ph 7.49 PaCO 37.8 mmhg PaO 67.4 mmhg HCO 3.6 meql B E 1. meql 141 meql K 3.9 meql Cl 108 meql Ca 8.4 mgdl P 4.5


救急車同乗実習レポート 総括

成人病(1).PDF

12„”‡Pfiú“ƒ-PDFŠp


() () () () () 175 () Tel Fax

小原 (7101).indd

2


日本呼吸器学会雑誌第44巻第6号

59 20 : 50 : : : : : 2 / :20 / 25 GTP /28 5/3 5/4 5/8 6/1 1 7kg 6/9 :178.7cm :68.55kg BMI:21.47 :37.3 :78 / :156/78mmHg 1

Behçet 病,サルコイドーシス,再発性多発軟骨炎―診断と鑑別を中心にー


_”÷’X


小児感染免疫第25巻第2号

051


Slide

20-121

抄録/抄録1    (1)V

溶血性尿毒症症候群 ver 最終.pptx

コロイド化学と界面化学

町田ボルナ獣医神経病 のコピー


untitled




…h…L…–…†…fi…g1

HOE901 A S S Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Gly

.n.s.N.._...{.\1

28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90

mg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD

無印良品 2012 自転車 カタログ

評価結果報告書の概要版(平成20年度)

2015電磁波_歯科医.rtfd


WBC 5700 / l Gran 58.5% Lym 29.0% Eosin 0.3% RBC 499x10 6 / l Hb 14.8 g/dl Hct 44.40% PLT 15.3x10 3 / l PT 157% Fbg 616 mg/dl DD 0.99 g/ml GOT GPT LDH

日本呼吸器学会雑誌第44巻第7号

Transcription:

CT MRI CSFCSF CSF CSF CSF CSF CSF (cisternal puncture) CSF 20-23G 90 (20-23G) : CSF <0.2ml/kg CSF

5 CSF 6 CSF 7 CSF CSF CDV CDV GFAP CSF Pandy test NSE MBP LDH 6.2 16.3 mu/ml 0-5 /µl AST 3.4 26.3 mu/ml CK 0 69.7 mu/ml <25 mg/dl<45 mg/dl GLU 34 140.9 mg/dl Pandy test Cl - 122.3 134.7 meq/l 1.004-1.006 Ca 2+ 2.5 3.7 meq/l ph 7.3-7.4 Albumin 10-20 mg/dl NSE 3.9 21.8 ng/ml <1.4 cmh 2 O MBP 0 1.3 ng/ml (n=30) 14

0µL 50µL Pandy test50µl 50µL 200-300µL 500µL CDVFCoV 100-500µL GFAP 200µL NSE300µL MBP600µL HVA ph50µl 100µL LDH10µL AST10µL CK 10µL Glu10µL Cl - 30µL Ca 2+ 10µL Albumin500µL CSF 30 CSF

/ / I D y m M F ( ) mg/dl <25 mg/dl Pandy test 1.004-1.006 ph 7.3-7.4 WBC /µl RBC /µl M= % N= % Ly= % Eo= % Bas= % LDH mu/ml 6.2-16.3 AST mu/ml 3.4-26.3 CDV CK mu/ml 0-69.7 Glucose mg/dl 30-140.9 Glucose mg/dl CSF/ % Cl - meq/l 122.3-134.7 Ca 2+ meq/l 2.5-3.7 Albumin mg/dl 10-20 NSE ng/ml 3.9 21.8 MBP mu/ml 0 1.3 CDV S-100 HVA mu/ml 98.212.4 CDV CSF: FIP CSF: GFAP Version

CSF CSF ()(10h15days) CSF () >500/µL CSF 30 CSF Fuchs-Rosenthal Neubauer Neubauer Deep 1/10mm 1mm A C B D (A+B+C+D) 4 10 = (mm 3 )(µl) 1mm CSF 500 1 100 1 WBC RBC 0-5/µL 0-3/µL CSF Cytospin 3mL 5mL CSF CSF 0.30.5mL 2530 Wright-Giemsa ()

Cytocrip Slide Clip Cytocrip Slide Clip 100µL CSF Sample Chamber 750rpm64G 5 Wright-Giemsa Chamber Cytospin 1000rpm 55G 11% 48! GME FIP

CSF <25 mg/dl<45 mg/dl Pandy test 30mg/dL 1) 23mL 2) CSF 12 3) 3 4) 1.004-1.006 ph ph ph 7.3-7.4 34 ( S.intermedius)PCR 200mmH 2 O CSF CSF CSF 1.3cmH 2 O=mmHg <1.4cm H 2 O

CSF CSF CSF LDH ASTCKGLU(Na C1 - Ca 2+ ) (LDH) LDH CSF LDH CSF LDH 510% 90% 10% CDV LDH LDH LDH CSF ;(LDH2.3.4 ) 6.2-16.3 mu/ml (12-55mU/mL; Abate et al.) () LDH-1 LDH-2 LDH-3 LDH-4 LDH-5 47.3±7.3 28.8 3.6 13.7±2.6 4.8±2.0 9.0±7.8 (%) Mean±S.D. (n=30) (AST) AST CSF AST Abate CDV AST CDV AST CDV MRI AST 3.4-26.3 mu/ml (9-46 mu/ml; Abate et al.) CDV (CK) CK M() B()CSF CK MRI

150 mu/ml CSF CK CK (100 150mU/mL) CK-BB 0-69.7 mu/ml CDV (GLU) CSF GLU 60-80CSF GLU CSF GLU MRI CDV CSF GLU MRI CDV CSF GLU CSF 34-140.9 mg/dl (50-105 mg/dl; Benjamin) 60-80% (Cl - ) CSF Cl - Donan 1/3 CSF Cl - Cl - Cl - CSF Cl - CSF CSF CSF Cl - Cl - MRI 130meq/L Cl - 122.3-134.4 meq/l (131-138 meq/l; Feldman)

(Ca 2+ ) Ca2 2+ CSF Ca 2+ CSF 2.5-3.7 meq/l BBB CSF 10-20 mg/dl; Sarjoner BBB CSF CSF CSF (NSE)NSE S-100 (MBP) CDV MBP (NSE) NSE γ 1% NSE CSF NSE MRI NSE

3.9-21.8 ng/ml (<10 ng/ml: Hara et al.) (MBP) MBP CSF MBP CDV CDV CSF MBP MBP CDV CDV MRI MBP 0-1.3 ng/ml CDV S-100 S-100 S-100 CSF S-100 2 Creutzfeldt-Jakob HVA HVA 98.2912.42; Vaughn, DM.? CSF GFAP GFAP CSF GFAP CSF GFAP 90%

CSF CDV CDV CDV CDV CDV CSF CDV CDV CSF CDV CSF CDVCDV CDV CDV CDV CSF CDV CDV CDV CSF IgG 6 CSF IgG / IgG IgG CSF / CDV RT-PCR RT-PCR CDV CSF CDV RT-PCR CSF CDV CSF CSF (mg/dl) (g/dl)10 CDV CDV 1mL PCR IgG IgM CSF CSF 0.1mL 0.1mL IP ELISA CSF ELISA CSF RT-PCR IDEXX Laboratories CDV IgM IgG PHA CDV IgG IgM PHA IgGM CSF 0.3mL 0.3mL 0.3mL 0.5mL ELISA RT-PCR ELISA ELISA PHA RT-PCR RT-PCR PCR ELISA PHA ELISA

CSF FIP FCoV FIP FIP FIP FCoV FCoV FIP FIP FIP FCoV FIP FCoV FIP FCoV FIP FCoV FCoV FIP CSF FCoV CSF FCoV FIP FCoV CSF FCoV FIP CSF FCoV FCoV CSF 0.1mL ELISA 0.3mL PCR IPA IFA IDEXX Laboratories IPA CSF / CSF CSF 250300pg/ml 80 pg/ml MRI 250-300 pg/ml < 80pg/ml

CSF Pandy 1. O1iver, EJ., Lorenz, MD. and Kornegay, JN. Handbook of Veterinary NeurologyW.B Saunders Co., Philadelphia1997. 2. Nelson, RW., Couto, CG.. Small Animal Interna1 Medicine, Mosby, St Louis, 1998. 3. Delahunta, AD. Veterinary Neurology and Clinical Neurology. W.B.Saunders Co., Philadelphia, 1983. 4..... 1998. 5.,,.... 1998. 6.. Dr. Bagley... 2008. 7. Vandevelde, M. and Spana, J.S. Cerebrospinal fluid cytology in canine neurologic disease. Am. J. Vet. Res. 38(11):1827-1831.1977. 8. Abate, O., Bollo, E., Lotti, D.and Bo, S. Cytological, immunological and biochemical cerebrospinal fluid investigations in selected central nervous system disorders of dogs. J. Vet. Med. B, 45:73-85. 1998. 9. Summers, BA., Whitaker, JN. and Appe1, MJ. Demyelinating canine distemper encephalitis: measurement of myelin basic protein in cerebrospinal fluid. J. Neuroimmunol. 14(2):227-233. 1987. 10.,,, NSE S-100.52(2):141-147.1977. 11.,,,. Neuron Specific Enolase: NSE NSE.. 5:3-14. 1998. 12. Vandeverde, M., Kristensen, F., Kristensen, B., Steck, A.J. and Kihm, U. Immunological and pathological findings in demyelinating encephalitis associated with canine distemper virus infection. Acta. Neuropathol, 56(1):1-8.1982. 13. Vaughn, DM., Coleman, E., Simpson, ST., Whitmer, B. and Satjawatcharaphong, C. A rostrocaudal gradient for neurotransmitter metabolites and a caudorostal gradient for protein in canine cerebrospinal fluid. Am. J. Vet. Res. 49(12):2134-2137.1988. 14... InfoVets. 10(11):4-8. 2007. 15... InfoVets. 10(11):8-12. 2007. 16... InfoVets. 10(11):13-21. 2007.